De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection

45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches

(2016) Heidi Barth et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Strategies to prevent BK virus infection in kidney transplant recipients

(2016) Alissa J. Wright et al.   CURRENT OPINION IN INFECTIOUS DISEASES

In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss

(2016) M. Mohamed et al.   Transplant Infectious Disease

BK Polyomavirus and the Transplanted Kidney

(2016) Caroline Lamarche et al.   TRANSPLANTATION

Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure

(2016) Sobhana Thangaraju et al.   TRANSPLANTATION

Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development

(2016) Emilio Rodrigo et al.   TRANSPLANTATION

Strategic Use of Epitope Matching to Improve Outcomes

(2016) Chris Wiebe et al.   TRANSPLANTATION

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients WithDe NovoDonor-Specific Antibody

(2015) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Modelling immune response to BK virus infection and donor kidney in renal transplant recipients

(2015) H.T. Banks et al.   INVERSE PROBLEMS IN SCIENCE AND ENGINEERING

Onset and progression ofde novodonor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction

(2015) G. Dieplinger et al.   Transplant Infectious Disease

Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

(2014) M. Haas et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-specific antibodies in allograft recipients

(2014) Stanley C. Jordan et al.   Current Opinion in Organ Transplantation

Persistent BK Viremia Does Not Increase Intermediate-Term Graft Loss but Is Associated with De Novo Donor-Specific Antibodies

(2014) D. Sawinski et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

BK virus infection: an update on diagnosis and treatment

(2014) D. Sawinski et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Late Antibody-Mediated Rejection in Renal Allografts

(2014) Gaurav Gupta et al.   TRANSPLANTATION

Class II HLA Epitope Matching-A Strategy to MinimizeDe NovoDonor-Specific Antibody Development and Improve Outcomes

(2013) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A cautionary tale of BK virus

(2013) Matthew Gillespie et al.   TRANSPLANT INTERNATIONAL

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

(2013) Matthew J. Everly et al.   TRANSPLANTATION

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

(2012) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results

(2010) K. L. Hardinger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy

(2010) S. Schaub et al.   AMERICAN JOURNAL OF TRANSPLANTATION

De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

(2009) L. G. Hidalgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Does Reduction in Immunosuppression in Viremic Patients Prevent BK Virus Nephropathy in De Novo Renal Transplant Recipients? A Prospective Study

(2009) Cyrielle Alméras et al.   TRANSPLANTATION

Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation

(2008) J. M. Burns et al.   AMERICAN JOURNAL OF TRANSPLANTATION